BlueBrainBoost
freedom-pharmacy
Purchases through the above links give commission which helps fund this website
Recent literature: Biogenic amine reuptake inhibitor
Date Journal Article title
2018 Encephale [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
2017 Dec Brain Res Monoamine involvement in the antidepressant-like effect induced by P2 blockade.
2018 May Neuropharmacology Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.
2017 Jul Int J Neuropsychopharmacol Effect of Physical Exercise and Acute Escitalopram on the Excitability of Brain Monoamine Neurons: In Vivo Electrophysiological Study in Rats.
2017 Aug Eur J Pharmacol Mechanistic evaluation of tapentadol in reducing the pain perception using in-vivo brain and spinal cord microdialysis in rats.
2016 CNS Neurosci Ther Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects.
2016 Jan J Ethnopharmacol High-mesembrine Sceletium extract (Trimesemine™) is a monoamine releasing agent, rather than only a selective serotonin reuptake inhibitor.
2016 J Pharmacol Sci Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats.
2015 Pain Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations.
2015 Jun Neuroscience Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
2015 J Pharmacol Exp Ther Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
2014 Oct Int J Neuropsychopharmacol Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
2014 Oct Int J Neuropsychopharmacol Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
2014 Nov Environ Sci Technol The antidepressant venlafaxine disrupts brain monoamine levels and neuroendocrine responses to stress in rainbow trout.
2015 J Neurosci Res The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression.
2014 Apr Eur J Pharmacol Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum.
2014 Feb Eur J Pharmacol Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.
2014 Feb Neuroscience Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus.
2013 Drugs Today (Barc) Current pharmacotherapy of attention deficit hyperactivity disorder.
2013 PLoS One Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
2013 PLoS One Aminergic control of social status in crayfish agonistic encounters.
2013 Parasitol Int Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
2012 Zh Vyssh Nerv Deiat Im I ... [Study on the effect of selective serotonin reuptake inhibitor fluoxetine on seizures and inborn behavior of rats with different phenotype of the nervous system].
2013 Apr Respir Physiol Neurobiol Fluoxetine augments ventilatory CO2 sensitivity in Brown Norway but not Sprague Dawley rats.
2013 Pharmacol Biochem Behav Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficithyperactivity disorder.
2013 J Pain Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.
2013 Eur Rev Med Pharmacol Sci Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
2013 J Neurophysiol Constitutively active 5-HT2α1 receptors facilitate muscle spasms after human spinal cord injury.
2013 Neuropharmacology Brain monoamines and antidepressant-like responses in MRLMpJ versus C57BL6J mice.
2013 Curr Pharm Des Inhibitor design for monoamine oxidases.
2012 Pharmacol Biochem Behav The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
2012 Neuropharmacology The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels.
2011 Nov Neuroscience Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
2012 J Neural Transm (Vienna) Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells.
2011 Jun J Neurosci Prefrontal and monoaminergic contributions to stop-signal task performance in rats.
2011 Neurochem Int Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
2010 Sep J Pharmacol Exp Ther Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
2010 Clin Pharmacol Ther Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
2010 Jun Eur J Pharmacol The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.
2010 Pharmacol Biochem Behav Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
2010 Mar J Med Chem 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.
2010 Comp Biochem Physiol C To... Biogenic amines modulate pulse rate in the dorsal blood vessel of Lumbriculus variegatus.
2009 Trends Pharmacol Sci Glutamate-based antidepressants: 20 years on.
2009 Nov Prog Neuropsychopharmacol... Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.
2009 Curr Pharm Des Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.
2009 Neurotherapeutics Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?
2009 Mar Prog Neuropsychopharmacol... Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.
2009 Jan Bioorg Med Chem Lett 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.
2009 Eur J Nucl Med Mol Imaging Monoamine transporter availability in Parkinson's disease patients with or without depression.
2009 Synapse Monoaminergic modulation of emotional impact in the inferomedial prefrontal cortex.
2008 J Neural Transm (Vienna) Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.
2009 Int J Dev Neurosci Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine.
2009 Neurochem Res Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
2008 Oct Brain Res Maternal para-chlorophenylalanine exposure modifies central monoamines and behaviors in the adult offspring.
2008 Arch Neurol Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
2008 Obesity (Silver Spring) Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease.
2008 Apr Eur J Pharmacol Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
2007 Expert Opin Investig Drugs Triple uptake inhibitors: therapeutic potential in depression and beyond.
2007 Synapse Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels.
2006 CNS Drug Rev Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.
2006 Neurosci Behav Physiol The effects of fluoxetine and its complexes with glycerrhizic acid on behavior in rats and brain monoamine levels.
2006 Mar Life Sci Hormones in the nucleus. Immunologically demonstrable biogenic amines (serotonin, histamine) in the nucleus of rat peritoneal mast cells.
2006 Feb Bioorg Med Chem Putative drug binding conformations of monoamine transporters.
2005 Jul Eur J Pharmacol Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.
2005 Jun Eur J Pharmacol Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
2005 Neuroscience Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction.
2005 Basic Clin Pharmacol Toxicol Antidepressants in the treatment of neuropathic pain.
2005 Feb Bioorg Med Chem Lett Discovery and structure-activity relationships of novel selective norepinephrine and dual serotoninnorepinephrine reuptake inhibitors.
2004 J Clin Pharmacol DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile.
2004 Oct Eur J Pharmacol Locus coeruleus activity in perinatally protein-deprived rats: effects of fluoxetine administration.
2004 Dec Synapse Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats.
2004 J Psychopharmacol The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
2004 Biomed Chromatogr Efficiency of antidepressant drugs as monoamine reuptake inhibitors: analysis of the hydrophobicity influence using biopartitioning micellar chromatographic data.
2004 Prog Neuropsychopharmacol... Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
2004 Am J Psychiatry Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.